OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.275
-0.005 (-0.39%)
Jan 29, 2026, 10:30 AM EST - Market open

OPKO Health Revenue

OPKO Health had revenue of $151.67M in the quarter ending September 30, 2025, a decrease of -12.65%. This brings the company's revenue in the last twelve months to $642.07M, down -9.75% year-over-year. In the year 2024, OPKO Health had annual revenue of $713.14M, down -17.41%.

Revenue (ttm)
$642.07M
Revenue Growth
-9.75%
P/S Ratio
1.45
Revenue / Employee
$214,237
Employees
2,997
Market Cap
978.82M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024713.14M-150.35M-17.41%
Dec 31, 2023863.50M-140.70M-14.01%
Dec 31, 20221.00B-770.52M-43.42%
Dec 31, 20211.77B339.31M23.64%
Dec 31, 20201.44B533.48M59.15%
Dec 31, 2019901.94M-88.33M-8.92%
Dec 31, 2018990.27M24.26M2.51%
Dec 31, 2017966.01M-151.49M-13.56%
Dec 31, 20161.12B625.76M127.25%
Dec 31, 2015491.74M400.61M439.63%
Dec 31, 201491.13M-5.41M-5.60%
Dec 31, 201396.53M49.49M105.19%
Dec 31, 201247.04M19.07M68.14%
Dec 31, 201127.98M-515.00K-1.81%
Dec 31, 201028.49M24.08M544.95%
Dec 31, 20094.42M-5.02M-53.20%
Dec 31, 20089.44M8.59M1,014.52%
Dec 31, 2007847.00K--
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Neogen880.32M
Myriad Genetics825.30M
NeoGenomics709.16M
GeneDx Holdings402.19M
Twist Bioscience376.57M
CareDx358.00M
Castle Biosciences343.53M
Fulgent Genetics315.55M
Revenue Rankings